Obesity
|
0.300 |
Biomarker
|
disease |
CTD_human |
The role of Pex11a in dyslipidaemia and obesity is investigated here with Pex11a knockout mice (Pex11a<sup>-/-</sup> ).
|
30585412 |
2019 |
Dyslipidemias
|
0.300 |
Biomarker
|
group |
CTD_human |
The role of Pex11a in dyslipidaemia and obesity is investigated here with Pex11a knockout mice (Pex11a<sup>-/-</sup> ).
|
30585412 |
2019 |
Dyslipoproteinemias
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Pex11a deficiency causes dyslipidaemia and obesity in mice.
|
30585412 |
2019 |
Zellweger Syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
|
25608554 |
2015 |
Peroxisome Proliferation
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
|
25608554 |
2015 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Zellweger Syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PEX11 promotes peroxisome division independently of peroxisome metabolism.
|
11839773 |
2002 |
Peroxisome Proliferation
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Based on these and other observations, we propose that PEX11 proteins act directly in peroxisome division, and that their loss has indirect effects on peroxisome metabolism.
|
11839773 |
2002 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Hepatocarcinogenesis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We evaluated the methylation status in the CpG islands of four deregulated genes (Casp3, Cldn1, Pex11a and Nox4) using methylation-sensitive high-resolution melting technology for the samples obtained from different stages of hepatocarcinogenesis.
|
27895046 |
2017 |